174 related articles for article (PubMed ID: 33410233)
1. Benzofuroxan Derivatives as Potent Agents against Multidrug-Resistant Mycobacterium tuberculosis.
Fernandes GFS; Campos DL; Da Silva IC; Prates JLB; Pavan AR; Pavan FR; Dos Santos JL
ChemMedChem; 2021 Apr; 16(8):1268-1282. PubMed ID: 33410233
[TBL] [Abstract][Full Text] [Related]
2.
Deb PK; Al-Shar'i NA; Venugopala KN; Pillay M; Borah P
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):869-884. PubMed ID: 34060396
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activity of furoxan derivatives against Mycobacterium tuberculosis.
Fernandes GFDS; de Souza PC; Marino LB; Chegaev K; Guglielmo S; Lazzarato L; Fruttero R; Chung MC; Pavan FR; Dos Santos JL
Eur J Med Chem; 2016 Nov; 123():523-531. PubMed ID: 27508879
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
[TBL] [Abstract][Full Text] [Related]
5. In silico Design and Synthesis of Tetrahydropyrimidinones and Tetrahydropyrimidinethiones as Potential Thymidylate Kinase Inhibitors Exerting Anti-TB Activity Against
Venugopala KN; Tratrat C; Pillay M; Chandrashekharappa S; Al-Attraqchi OHA; Aldhubiab BE; Attimarad M; Alwassil OI; Nair AB; Sreeharsha N; Venugopala R; Morsy MA; Haroun M; Kumalo HM; Odhav B; Mlisana K
Drug Des Devel Ther; 2020; 14():1027-1039. PubMed ID: 32214795
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and in vitro antituberculosis activity of benzo[6,7]cyclohepta[1,2-b]pyridine-1,3,4-oxadiazole derivatives.
Sajja Y; Vanguru S; Vulupala HR; Nagarapu L; Perumal Y; Sriram D; Nanubolu JB
Chem Biol Drug Des; 2017 Oct; 90(4):496-500. PubMed ID: 28267891
[TBL] [Abstract][Full Text] [Related]
7. Preparation and in vitro evaluation of benzylsulfanyl benzoxazole derivatives as potential antituberculosis agents.
Klimesová V; Kocí J; Waisser K; Kaustová J; Möllmann U
Eur J Med Chem; 2009 May; 44(5):2286-93. PubMed ID: 18694614
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and antimycobacterial evaluation of novel adamantane and adamantanol analogues effective against drug-resistant tuberculosis.
Alsayed SSR; Lun S; Payne A; Bishai WR; Gunosewoyo H
Bioorg Chem; 2021 Jan; 106():104486. PubMed ID: 33276981
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide.
Villar R; Vicente E; Solano B; Pérez-Silanes S; Aldana I; Maddry JA; Lenaerts AJ; Franzblau SG; Cho SH; Monge A; Goldman RC
J Antimicrob Chemother; 2008 Sep; 62(3):547-54. PubMed ID: 18502817
[TBL] [Abstract][Full Text] [Related]
10. Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design.
Pieroni M; Wan B; Zuliani V; Franzblau SG; Costantino G; Rivara M
Eur J Med Chem; 2015 Jul; 100():44-9. PubMed ID: 26071857
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of (E)-5-styryl-1,2,4-oxadiazoles as anti-tubercular agents.
Atmaram Upare A; Gadekar PK; Sivaramakrishnan H; Naik N; Khedkar VM; Sarkar D; Choudhari A; Mohana Roopan S
Bioorg Chem; 2019 May; 86():507-512. PubMed ID: 30776681
[TBL] [Abstract][Full Text] [Related]
12. Furoxan derivatives demonstrated in vivo efficacy by reducing Mycobacterium tuberculosis to undetectable levels in a mouse model of infection.
de Souza PC; Fernandes GFS; Marino LB; Ribeiro CM; Silva PBD; Chorilli M; Silva CSP; Resende FA; Solcia MC; de Grandis RA; Costa CAS; Cho SH; Wang Y; Franzblau SG; Dos Santos JL; Pavan FR
Biomed Pharmacother; 2020 Oct; 130():110592. PubMed ID: 32763822
[TBL] [Abstract][Full Text] [Related]
13. New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: Synthesis, antimycobacterial activity and investigation of their mechanism of action.
Vosátka R; Krátký M; Švarcová M; Janoušek J; Stolaříková J; Madacki J; Huszár S; Mikušová K; Korduláková J; Trejtnar F; Vinšová J
Eur J Med Chem; 2018 May; 151():824-835. PubMed ID: 29679902
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of nitrofuran-1,3,4-oxadiazole hybrids as new antitubercular agents.
Wang A; Xu S; Chai Y; Xia G; Wang B; Lv K; Wang D; Qin X; Jiang B; Wu W; Liu M; Lu Y
Bioorg Med Chem; 2022 Jan; 53():116529. PubMed ID: 34861474
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of novel imidazo[1,2-a]pyridinecarboxamides as potent anti-tuberculosis agents.
Onajole OK; Lun S; Yun YJ; Langue DY; Jaskula-Dybka M; Flores A; Frazier E; Scurry AC; Zavala A; Arreola KR; Pierzchalski B; Ayitou AJ; Bishai WR
Chem Biol Drug Des; 2020 Dec; 96(6):1362-1371. PubMed ID: 32515129
[TBL] [Abstract][Full Text] [Related]
16. Novel 1,3,4-oxadiazoles as antitubercular agents with limited activity against drug-resistant tuberculosis.
Makane VB; Krishna VS; Krishna EV; Shukla M; Mahizhaveni B; Misra S; Chopra S; Sriram D; Azger Dusthackeer VN; Rode HB
Future Med Chem; 2019 Mar; 11(6):499-510. PubMed ID: 30892944
[TBL] [Abstract][Full Text] [Related]
17. Molecular properties prediction and synthesis of novel 1,3,4-oxadiazole analogues as potent antimicrobial and antitubercular agents.
Ahsan MJ; Samy JG; Khalilullah H; Nomani MS; Saraswat P; Gaur R; Singh A
Bioorg Med Chem Lett; 2011 Dec; 21(24):7246-50. PubMed ID: 22071303
[TBL] [Abstract][Full Text] [Related]
18. Novel 1-(4-substituted benzylidene)-4-(1-(substituted methyl)-2,3-dioxoindolin-5-yl)semicarbazide derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) and MDR-TB strain.
Raja S; Prakash CR
Arch Pharm Res; 2013 Apr; 36(4):411-22. PubMed ID: 23440582
[TBL] [Abstract][Full Text] [Related]
19. Searching for New Leads for Tuberculosis: Design, Synthesis, and Biological Evaluation of Novel 2-Quinolin-4-yloxyacetamides.
Pitta E; Rogacki MK; Balabon O; Huss S; Cunningham F; Lopez-Roman EM; Joossens J; Augustyns K; Ballell L; Bates RH; Van der Veken P
J Med Chem; 2016 Jul; 59(14):6709-28. PubMed ID: 27348630
[TBL] [Abstract][Full Text] [Related]
20. Recent developments of coumarin-containing derivatives and their anti-tubercular activity.
Hu YQ; Xu Z; Zhang S; Wu X; Ding JW; Lv ZS; Feng LS
Eur J Med Chem; 2017 Aug; 136():122-130. PubMed ID: 28494250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
